Robert J. Dalton

Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

Shaji Kumar, Joseph Mıkhael, Francis K. Buadi et al. · Mayo Clinic Proceedings · 2009 · 622 citations · Full text

Hematological Malignancy, Oncology, Clinical Epidemiology +8

Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013

Joseph Mıkhael, David Dingli, Vivek Roy et al. · Mayo Clinic Proceedings · 2013 · 485 citations

Hematological Malignancy, Oncology, Hematology +7

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.

Edward T. Creagan, Robert J. Dalton, David L. Ahmann et al. · Journal of Clinical Oncology · 1995 · 251 citations

Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement

Angela Dispenzieri, S. Vincent Rajkumar, Morie A. Gertz et al. · Mayo Clinic Proceedings · 2007 · 179 citations

Hematological Malignancy, Oncology, Hematology +7

Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement

Angela Dispenzieri, S. Vincent Rajkumar, Morie A. Gertz et al. · Mayo Clinic Proceedings · 2007 · 168 citations · Full text

Hematological Malignancy, Oncology, Hematology +7